- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Mark A. Jensen
News 14 results
Recognition
October 23, 2024
King & Spalding Earns Top Rankings in Legal 500 Latin America 2025 Guide
Recognition
October 9, 2024
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Recognition
September 19, 2024
King & Spalding Earns Multiple Rankings in LMG Life Sciences 2024 Guide
Recognition
June 12, 2024
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2024 Guide
Events 7 results
Webinar
April 29, 2025
FCA Enforcement and Litigation: How Recent Decisions and Policy Announcements Signal Key Changes
Conference
September 5, 2024
17th Annual King & Spalding Medical Device Summit
Conference
November 7, 2023
Pharmaceutical University 2023
Conference
November 1, 2022
Pharmaceutical University 2022
Insights 7 results
Client Alert
March 11, 2025
Recent Decisions and DOJ Policy Announcements Signal Key Changes to FCA Enforcement and Litigation Environment
Feature
December 12, 2023
General Counsel’s Decision Tree for Internal Investigations for the Life Sciences Industry
Feature
December 8, 2023
General Counsel’s Decision Tree for Internal Investigations for the Food and Beverage Industry
Feature
November 9, 2023
General Counsel’s Decision Tree for Internal Investigations for the Healthcare Industry